How to craft responsive clinical trials that are designed for success

October 29, 2019

Without the right design, right data and right decisions, idealised clinical trial plans cannot be translated into blueprints for robust studies.

Spotlight

Quest Nutra Pharma Group

Quest Nutra Pharma is a manufacturer of nutraceuticals, pharmaceuticals, food supplements, botanical extracts and flavours, with factories and entities in the United Kingdom and the United Arab Emirates. The group has its own brands of nutraceuticals and pharmaceuticals, offers contract manufacturing services to other businesses, and also supplies the pharmaceutical, agricultural and food industries with flavours and botanical extracts. The operating entities within the group consist of Quest Vitamins Ltd, Quest Ingredients Ltd (formerly Flavex International Ltd) and Quest Middle East FZE. The factories within the group are certified with pharmaceutical-grade GMP by the UK's Medicines and Healthcare products Regulatory Agency (MHRA) and by other regulators around the world. The factories also have certifications for BRC Grade A, ISO 9001, FEMAS and SEDEX.

OTHER WHITEPAPERS
news image

A BLOCKCHAIN TO ENSURE COUNTERFEIT FREE PHARMACEUTICAL SUPPLY CHAIN

whitePaper | February 5, 2022

Essential medicine access is one of the main objectives of healthcare systems in and pharmaceutical supply chains ensure that the right amount of medicine, with acceptable quality, will reach the customers in need

Read More
news image

How Cellular is Enabling the Digital Supply Chain

whitePaper | January 12, 2020

Supply chains grow more and more complex every day. In response, manufacturers and shippers have been eagerly exploring digital tools that provide actionable insight into the location and condition of in-transit goods. Although there are many technology options when it comes to building a digital supply chain, one type of solution stands out as the most reliable and cost-effective: cellular.

Read More
news image

The Impact of Rising Generic Drug Prices on the U.S. Drug Supply Chain

whitePaper | April 16, 2020

Over the past two years, the pharmacy industry has seen unprecedented increases in the prices of generic drugs, causing unexpected cost increases for payers and consumers, and spurring an investigation by the United States Congress. High generic drug prices have had an adverse effect on almost everyone in the pharmaceutical supply chain. Consumers face higher co-pays and prices and health plans are dealing with higher drug spend. Physicians are finding the need to prescribe alternative drug therapies while dealing with angry patients.

Read More
news image

Research and Development in the Pharmaceutical Industry

whitePaper | April 1, 2021

Every year, the U.S. pharmaceutical industry develops a variety of new drugs that provide valuable medical benefits. Many of those drugs are expensive and contribute to rising health care costs for the private sector and the federal government. Policymakers have considered policies that would lower drug prices and reduce federal drug expenditures. Such policies would probably reduce the industry’s incentive to develop new drugs.

Read More
news image

Reimagining the pharma landscape with design thinking

whitePaper | July 29, 2021

As pharma companies strive for increased commercial success the customer-centric focus can get lost in the adoption of new commercial endeavours. As a result, many have been looking toward the world of design as a way of enhancing their customer engagement and accelerating their position in the market.

Read More
news image

Prescription Drug Pricing: How Lack of Transparency Reduces Market Access, Utilization, and Adherence

whitePaper | November 25, 2019

It's clear that healthcare prices weigh heavily on the minds of Americans, and the time has come for the pharmaceutical industry to take the reins of the prescription drug pricing dialogue with consumers.

Read More

Spotlight

Quest Nutra Pharma Group

Quest Nutra Pharma is a manufacturer of nutraceuticals, pharmaceuticals, food supplements, botanical extracts and flavours, with factories and entities in the United Kingdom and the United Arab Emirates. The group has its own brands of nutraceuticals and pharmaceuticals, offers contract manufacturing services to other businesses, and also supplies the pharmaceutical, agricultural and food industries with flavours and botanical extracts. The operating entities within the group consist of Quest Vitamins Ltd, Quest Ingredients Ltd (formerly Flavex International Ltd) and Quest Middle East FZE. The factories within the group are certified with pharmaceutical-grade GMP by the UK's Medicines and Healthcare products Regulatory Agency (MHRA) and by other regulators around the world. The factories also have certifications for BRC Grade A, ISO 9001, FEMAS and SEDEX.

Events